Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts PRVA Hot Sheet
Price: $22.89 +1.87%
Rating Summary:
24 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Rating Summary:
24 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Join SI Premium – FREE
Truist Securities analyst Jailendra Singh lowered the price target on Privia Health Group Inc (NASDAQ: PRVA) to $28.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "We had a post quarterly conference call with PRVA management to discuss its 4Q23 results, 2024 outlook, views on capitation, etc. The answers are not verbatim, but we put the company’s answers in their proper context in a give and take format. With this note, we are updating our PT to $28 (previously $32)."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- argenx SE (ARGX) PT Raised to $861 at Baird
- Lam Research (LRCX) PT Lowered to $350 at Bernstein SocGen Group
- Spotify (SPOT) PT Raised to $625 at Raymond James
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
